Press Releases
Achieving Faster Investigational New Drug Timelines with a Robust Cell Line Development Strategy
MEDIA FOCUS
Achieving Faster Investigational New Drug Timelines with a Robust Cell Line Development Strategy
Youlim Kim
Lead Scientist, Cell Line Development
Technological advances in drug manufacturing equipment and process optimization play a significant role in increasing speed to market of critical biologic drugs. In this article, Youlim Kim, our Lead Scientist in Cell Line Development, explores the challenges associated with CLD and offers an expert look into the tactics CDMOs can employ to shorten commercial timelines while preserving quality and yield.
MEDIA FOCUS
Achieving Faster Investigational New Drug Timelines with a Robust Cell Line Development Strategy
Youlim Kim
Lead Scientist, Cell Line Development
Technological advances in drug manufacturing equipment and process optimization play a significant role in increasing speed to market of critical biologic drugs. In this article, Youlim Kim, our Lead Scientist in Cell Line Development, explores the challenges associated with CLD and offers an expert look into the tactics CDMOs can employ to shorten commercial timelines while preserving quality and yield.